文献速递腹部泌尿生殖CT

肝细胞癌治疗后随访肝脏CT加做盆腔覆盖的增益价值

Added Value of Pelvic CT after Treatment of HCC.
PubMed 文献 · Radiology · 2023-02-21

本回顾性研究纳入1122例肝细胞癌治疗后随访肝脏CT的患者,评估盆腔覆盖对检出盆腔转移或偶发肿瘤的增益价值。3年累积肝外转移率14.4%,孤立性盆腔转移率1.4%,偶发盆腔肿瘤率0.5%;盆腔覆盖使平扫和增强肝脏CT辐射剂量分别增加39%和29%。结论认为孤立性盆腔转移或偶发盆腔肿瘤发生率低。

要点

  • 肝细胞癌治疗后随访肝脏CT中,孤立性盆腔转移和偶发盆腔肿瘤的3年累积发生率分别仅1.4%和0.5%。
  • 仅T分期与孤立性盆腔转移相关(P = .01),提示可据此选择性决定是否加做盆腔覆盖。
  • 常规加做盆腔覆盖使平扫和增强肝脏CT辐射剂量分别增加39%和29%,需权衡获益与辐射风险。

核心结论

  • 肝细胞癌治疗后随访肝脏CT中,孤立性盆腔转移或偶发盆腔肿瘤的发生率低,常规盆腔覆盖的增益价值有限。

研究设计与样本

  • 回顾性研究纳入2016年1月至2017年12月诊断的1122例肝细胞癌患者,均为治疗后接受肝脏CT随访者(平均年龄60岁±10,896例男性)。
  • 采用Kaplan-Meier法估算肝外转移、孤立性盆腔转移和偶发盆腔肿瘤的累积率,Cox比例风险模型分析危险因素,并计算盆腔覆盖的辐射剂量。

诊断标准与关键数值

  • 3年累积肝外转移率为14.4%,孤立性盆腔转移率为1.4%,偶发盆腔肿瘤率为0.5%。
  • 调整分析中,维生素K缺乏或拮抗剂-II诱导蛋白(P = .001)、最大肿瘤大小(P = .02)、T分期(P = .008)和初始治疗方法(P < .001)与肝外转移相关。
  • 仅T分期与孤立性盆腔转移相关(P = .01)。
  • 盆腔覆盖使增强肝脏CT辐射剂量增加29%,平扫肝脏CT辐射剂量增加39%。

临床应用与阅片要点

  • 日常阅片时可结合T分期等危险因素,选择性决定肝细胞癌治疗后随访肝脏CT是否加做盆腔覆盖,而非常规包含。
  • 报告时应关注盆腔视野内是否存在偶发肿瘤,但需知晓其发生率仅0.5%。

局限性

  • 本研究为单中心回顾性设计,可能存在选择偏倚。
  • 原文未报告外部验证队列,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background In patients with hepatocellular carcinoma (HCC) who undergo follow-up with CT after treatment, the benefit of routinely including pelvic coverage is not well substantiated. Purpose To investigate the added value of pelvic coverage at follow-up liver CT in detecting pelvic metastasis or incidental tumors in patients treated for HCC. Materials and Methods This retrospective study included patients who were diagnosed with HCC between January 2016 and December 2017 and followed up with liver CT after treatment. Cumulative rates of extrahepatic metastasis, isolated pelvic metastasis, and incidental pelvic tumor were estimated by using the Kaplan-Meier method. Cox proportional hazard models were used to identify risk factors for extrahepatic and isolated pelvic metastases. Radiation dose from pelvic coverage was also calculated. Results A total of 1122 patients (mean age, 60 years ± 10 [SD]; 896 men) were included. The cumulative rates at 3 years of extrahepatic metastasis, isolated pelvic metastasis, and incidental pelvic tumor were 14.4%, 1.4%, and 0.5%, respectively. At adjusted analysis, protein induced by vitamin K absence or antagonist-II (P = .001), size of the largest tumor (P = .02), T stage (P = .008), and initial treatment method (P < .001) were associated with extrahepatic metastasis. Only T stage was associated with isolated pelvic metastasis (P = .01). Because of pelvic coverage, the radiation dose increased by 29% and 39% in liver CT with and without contrast enhancement, respectively, compared with CT scans without pelvic coverage. Conclusion The incidence of isolated pelvic metastasis or incidental pelvic tumor was low in patients treated for hepatocellular carcinoma. © RSNA, 2023.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yeom, Chi, Song, et al. Added Value of Pelvic CT after Treatment of HCC. Radiology. 2023. PMID: 36809213. doi:10.1148/radiol.222314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。